Zolidd® is a proprietary bioactive nanolayer with a bone-strengthening drug. With Zolidd® on an implant, the bone grows stronger, stability increases, and the risk of complications is reduced. When the implant with Zolidd® on is inserted into bone, the drug is made available to the bone surrounding the implant.
The Zolidd® Nanolayer
Zolidd® is a thin layer of a blood protein, and fully biocompatible. Any implant can be prepared with Zolidd®. Zolidd® will improve the bone holding power without affecting the underlying properties of the implant itself, and using it requiers no changes in the surgical procedures.
The drug used in Zolidd® is a bisphosphonate. Bisphosphonates are bone-strengthening drugs, and the most prescribed class of drugs for patients with weak bone. Bisphosphonates affect the bone metabolism locally, and when an implant with Zolidd® is placed in the bone, the effect of the drug will be on the bone surrounding the implant.